Skip to main content
Caplight Logo









Excelsior Sciences

Excelsior Sciences

Private
New York City, New YorkHealthcare & Life Scienceshttps://excelsiorsci.com/

Last Round

Series A

Dec 3, 2025

Est. Valuation

$96M

Total Funding Raised

$70M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Excelsior Sciences is a biotechnology company that develops an automated chemistry platform and a machine-native chemical language to accelerate the discovery and manufacturing of small molecules.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Data Integration, Workflow Automation

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

drug discoverycomputational biologylaboratory automationAI-native drug discoveryclosed-loop discoverypredictive modelinglead optimizationbiotech softwareSaaSin silico drug discoveryAI-guided synthesisR&D automationusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Excelsior Sciences Comparables

Compare Excelsior Sciences with similar companies based on industry and business-model similarity.

Excelsior Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DeepCure
87%
Synfini
86%
Iktos
80%

Excelsior Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 3, 2025

Key People

Founding team and executive leadership

Michael Foley

Chief Executive Officer and Co-Founder

Founding Team

Marc Feiglin

Chief Technology Officer

Executive Team

Jana Jensen

Chief Operating Officer

Executive Team

Excelsior Sciences Investors

Notable investors and investment history

Excelsior Sciences investors
InvestorRounds
MITSeries A
Deerfield ManagementSeries A
Cornucopian CapitalSeries A
Khosla VenturesSeries A
Empire State DevelopmentSeries A
Sofinnova PartnersSeries A
Illinois VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 54% MoM, from 1.3K to 2K.

  • Apr 11, 2026

    Grew 26% QoQ, from 19 to 24 employees.

Excelsior Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Excelsior Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Excelsior Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range25
Year Founded2024
Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?